Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases

source extracted confidence: high 2026-04-09
#3-hydroxyacyl-coa-dehydrogenases #amino-acid-metabolism-inborn-errors #brain-diseases-metabolic #cardiomyopathies #england

Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases

Moorthie et al., 2014 | J Inherit Metab Dis | Meta Analysis

Citation

Moorthie Sowmiya, Cameron Louise, ... Burton Hilary. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis. 2014-Nov;37(6):889-98. doi:10.1007/s10545-014-9729-0

Abstract

Many newborn screening programmes now use tandem mass spectrometry in order to screen for a variety of diseases. However, countries have embraced this technology with a differing pace of change and for different conditions. This has been facilitated by the ability of this diagnostic method to limit analysis to specific metabolites of interest, enabling targeted screening for particular conditions. MS/MS was introduced in 2009 in England to implement newborn bloodspot screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) raising the possibility of screening for other inherited metabolic disorders. Recently, a pilot screening programme was conducted in order to evaluate the health and economic consequences of screening for five additional inherited metabolic disorders in England. As part of this study we conducted a systematic review and meta-analysis to estimate the birth prevalence of these conditions: maple syrup urine disease, homocystinuria (pyridoxine unresponsive), glutaric aciduria type I, isovaleric acidaemia and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency including trifunctional protein deficiency. We identified a total of 99 studies that were able to provide information on the prevalence of one or more of the disorders. The vast majority of studies were of screening programmes with some reporting on clinically detected cases.

Key Findings

The vast majority of studies were of screening programmes with some reporting on clinically detected cases.

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size 99
Age Range See abstract
Condition deficiency

MeSH Terms

  • 3-Hydroxyacyl CoA Dehydrogenases
  • Amino Acid Metabolism, Inborn Errors
  • Brain Diseases, Metabolic
  • Cardiomyopathies
  • England
  • Glutaryl-CoA Dehydrogenase
  • Homocystinuria
  • Humans
  • Infant, Newborn
  • Isovaleryl-CoA Dehydrogenase
  • Lipid Metabolism, Inborn Errors
  • Maple Syrup Urine Disease
  • Mitochondrial Myopathies
  • Mitochondrial Trifunctional Protein
  • Neonatal Screening
  • Nervous System Diseases
  • Rhabdomyolysis
  • Tandem Mass Spectrometry

Evidence Classification

  • Level: Meta Analysis
  • Publication Types: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
  • Vertical: vitamin-b6

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09